CNS & Neurological Disorders - Drug Targets
Title Abbreviation
CNS Neurol Disord Drug Targets
Electronic ISSN
1996-3181
Readership
Cell Biologists, Clinical Pharmacologists, Medicinal Chemists, Molecular Biologists, Neurologists, Neuroscientists, Pharmacologists, Scientists
Scope
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.
CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Bentham Science Publishers Ltd.
To see more details about CNS & Neurological Disorders - Drug Targets,
Subscribe Now!
Impact Factor
Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines